A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease

NCT05036473 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: WD-1603 Carbidopa-Levodopa Extended-Release Tablets
DRUG: Placebo

Sponsor

Shanghai WD Pharmaceutical Co., Ltd.